Efficacy and Safety of Fitusiran Prophylaxis, an siRNA Therapeutic, in a Multicenter Phase 3 Study (ATLAS-INH) in People with Hemophilia A or B, with Inhibitors (PwHI)Guy Young, Savita Rangarajan, Kaan Kavaklı et al.|Blood|2021Cited by 16